Free discreet shipping on every order · Licensed pharmacy
Metformin CoGet started

Metformin ER / working resource

Observation and follow-up journal

Record what changed, when it changed and what else could explain it.

Start with the product-specific question

The boxed warning

Metformin ER, approved for type 2 diabetes, with the evidence and its limits for other uses in plain view. What should I know about the lactic acidosis warning?

In the 15-year follow-up of the Diabetes Prevention Program Outcomes Study, the cumulative incidences of diabetes at year 15 were 55% in the lifestyle group, 56% in the metformin group, and 62% in the placebo group.

Read the original record ↗
Open the Metformin ER library ↗

Describe an observation without assuming a cause.

When researching Metformin ER, stories about improvement can leave out other changes, time trends and ordinary variation. A clear record preserves those details. Use any monitoring plan agreed with your clinician; this blank journal does not supply one.

Entry 1

Entry 2

Entry 3

Entry 4

Review the record with context.

A personal timeline cannot establish that a product caused a benefit or harm. Seek appropriate care for concerning symptoms rather than waiting to complete a journal.

These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.

Explore all six resources ↗